Photograph of Aaron D. Pearson, Ph.D.

Education

  • Florida State University, B.S. chemistry
  • Colorado State University, Ph.D. organic chemistry
Aaron D. Pearson, Ph.D., Technical Specialist Washington, D.C.
apearson@crowell.com
Phone: +1 202.508.8865
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Dr. Aaron D. Pearson is a technical specialist in the Intellectual Property Group in Crowell & Moring's Washington, D.C. office. Aaron focuses on patent prosecution and provides technical analysis in the fields of organic chemistry and pharmaceutics, in support of patent counseling, opinion work, and litigation for the pharmaceutical industry.

Prior to joining Crowell & Moring, Aaron worked as a postdoctoral fellow at The Scripps Research Institute with CEO & vice-chair Peter G. Schultz, where he focused on protein engineering, developing antibody-drug conjugates and the design of small molecule inhibitors.

He received his doctorate at Colorado State University with University Distinguished Professor Robert M. Williams, where his research focused on the total synthesis of the neurotoxin zetekitoxin AB and related saxitoxin alkaloids. In addition, Aaron holds a B.S. in chemistry from Florida State University.

Aaron has experience with a variety of chemical and pharmaceutical technologies and biotechnologies, including small molecules, antibody-drug conjugates, and protein engineering.



Publications

  • "Targeted Delivery of an Anti-Inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-Drug Conjugate," Molecular Therapy 24, 2078-2089 (2016). Co-Author: Aaron D. Pearson.
  • "Trapping a Transition State in a Computationally Designed Protein Bottle," Science 347, 863-867 (2015). Co-Author: Aaron D. Pearson.
  • "Synthetic Studies Towards Zetekitoxin AB: Preparation of 4,5-epi-11-hydroxy-saxitoxinol," Tetrahedron 70, 7942-7949 (2014). Co-Author: Aaron D. Pearson.